Kistler-Tiffany Companies’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $35.9K | Hold |
500
| – | – | 0.01% | 533 |
|
|
2023
Q1 | $30.8K | Hold |
500
| – | – | 0.01% | 491 |
|
|
2022
Q4 | $38.6K | Hold |
500
| – | – | 0.01% | 453 |
|
|
2022
Q3 | $22K | Hold |
500
| – | – | 0.01% | 477 |
|
|
2022
Q2 | $19K | Hold |
500
| – | – | ﹤0.01% | 508 |
|
|
2022
Q1 | $21K | Hold |
500
| – | – | ﹤0.01% | 507 |
|
|
2021
Q4 | $19K | Hold |
500
| – | – | ﹤0.01% | 513 |
|
|
2021
Q3 | $16K | Hold |
500
| – | – | ﹤0.01% | 528 |
|
|
2021
Q2 | $34K | Hold |
500
| – | – | 0.01% | 412 |
|
|
2021
Q1 | $28K | Hold |
500
| – | – | 0.01% | 409 |
|
|
2020
Q4 | $41K | Hold |
500
| – | – | 0.01% | 323 |
|
|
2020
Q3 | $36K | Hold |
500
| – | – | 0.01% | 310 |
|
|
2020
Q2 | $41K | Hold |
500
| – | – | 0.01% | 274 |
|
|
2020
Q1 | $52K | Hold |
500
| – | – | 0.02% | 252 |
|
|
2019
Q4 | $52K | Hold |
500
| – | – | 0.02% | 257 |
|
|
2019
Q3 | $10K | Hold |
500
| – | – | ﹤0.01% | 443 |
|
|
2019
Q2 | $13K | Buy |
+500
| New | +$13K | ﹤0.01% | 408 |
|